2023 Industry Programme

 

11:30am – 12:30pm MedTech and Diagnostics Regulation Briefing

Medical Devices and Diagnostics. With IMDRF on the horizon as well as the MHRA looking to participate this will be a valuable forward looking discussion. 

Andrew Davies, Digital Health Lead, The Association of British HealthTech Industries (ABHI)

Stephen Hull, Founder and President, Hull Associates

Laurie Rowe, Founder & Director, Medical Device Consultant, Red Medtech

 

12:30 – 1:30pm Finance, Funding and Business Support

This session will look at the finance schemes and funding support available to businesses.

Julie Russell, Business Development Manager – Inward Investment, Welsh Government

Dr Chris Rowe, Innovation Lead – Medical Technology, Innovate UK 

Investor Panel Discussion:

Annamarie Saarinen, CEO, Bloom Standard

Dr Claire Button, Plutus Investment Group LLP

Dr Richard Thompson, Senior Investment Executive, Development Bank of Wales

John McKinley, CEO, Imspex Diagnostics 

Simon Hoad, Executive Director, The Pioneer Group

 

3:30 – 4:30pm UK Market Access, Procurement and NHS Supply Chain

Discussion around the social value, UK resilience, decarbonisation and value based procurement. The session will aim to explain the various types of evidence and data that manufacturers may need to be able to win business with the Welsh NHS.  It will cover test data, standard and regulatory compliance, NICE guidance, Health Technology Assessments (HTAs), and national initiatives such as the National Joint Registry.

Andrew Davies, Digital Health Lead, The Association of British HealthTech Industries (ABHI)

Matthew Prettyjohns, Principal Researcher, Health Technology Wales

National Welsh Shared Services Programme (NWSSP)